GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Common Stock

Concord Biotech (BOM:543960) Common Stock : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Common Stock?

Concord Biotech's quarterly common stock increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹105 Mil) but then declined from Sep. 2024 (₹105 Mil) to Dec. 2024 (₹0 Mil).

Concord Biotech's annual common stock increased from Mar. 2022 (₹95 Mil) to Mar. 2023 (₹105 Mil) but then stayed the same from Mar. 2023 (₹105 Mil) to Mar. 2024 (₹105 Mil).


Concord Biotech Common Stock Historical Data

The historical data trend for Concord Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Common Stock Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Common Stock
95.11 95.11 95.11 104.62 104.62

Concord Biotech Quarterly Data
Mar20 Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 104.62 - 104.62 -

Concord Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Concord Biotech Business Description

Traded in Other Exchanges
Address
Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products.

Concord Biotech Headlines

No Headlines